The DOI matches its Crossref record; 472 of the 472 references it cites were found in a registry or an index.
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Open accessAbstract
The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An extensive literature implicates shared alterations in the reward circuitry in MDD, neurodegenerative disorders, and obesity261-263.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [263]
In the citing paper
“One of the reasons that hinder the diagnosis and treatment of this disorder is the lack of complete understanding of the underlying molecular pathology [16].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
In the citing paper
“DA plays an essential role in mediating regulation of the cortical system, memory, mood, vascular structure, anticipation of events, motivation, behaviour inhibition, decision-making and problem-solving [16, 81, 82].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
Citations
Cites
(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,150
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Flagged first, then by citations
Research works printed but not linked: 4
- Dale H (1935) Pharmacology and nerve-endings: Walter Ernest Dixon Memorial Lecture. Proc R Soc Med 28:319–332
- Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104
- Hohman LB (1922) Post-encephalitic behavior disorders in children. Johns Hopkins Hospt Bull 33:372–375
- Stryker S (1925) Encephalitis lethargica—the behavior residuals. Train Sch Bull (Vinel) 22:152–157
Cited by
Sorted by citations
Items 101–200 of 999
Fisher, N. M., Gould, R. W., Gogliotti, R. G., McDonald, A. J., Badivuku, H., Chennareddy, S., Buch, A. B., Moore, A. M., Jenkins, M. T., Robb, W. H., et al. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12654 · Cited by 39
Costanzi, M., Cianfanelli, B., Santirocchi, A., Lasaponara, S., Spataro, P., Rossi-Arnaud, C., & Cestari, V. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040241 · Cited by 39
Dopaminergic Axons: Key Recitalists in Parkinson’s Disease
Mishra, A. K., & Dixit, A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03464-1 · Cited by 37
Olfactory dysfunction and its related molecular mechanisms in Parkinson’s disease
Gu, Y., Zhang, J., Zhao, X., Nie, W., Xu, X., Liu, M., & Zhang, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380875 · Cited by 41
From Enzymatic Dopamine Biosensors to OECT Biosensors of Dopamine
Ravariu, C. (2023) · Biosensors · doi:10.3390/bios13080806 · Cited by 38
Pan, J., Liu, M., Li, D., Zheng, H., & Zhang, D. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.09.005 · Cited by 38
Mariggiò, M. A., Palumbi, R., Vinella, A., Laterza, R., Petruzzelli, M. G., Peschechera, A., Gabellone, A., Gentile, O., Vincenti, A., & Margari, L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.705890 · Cited by 40
Boruah, P. K., Borthakur, P., Neog, G., Ouay, B. L., Afzal, N. U., Manna, P., & Das, M. R. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c04582 · Cited by 37
Battaglia, S., Nazzi, C., & Thayer, J. F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02737-x · Cited by 36
Inflammation, Dopaminergic Brain and Bilirubin
Jayanti, S. D., Verde, C. D., Tiribelli, C., & Gazzin, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411478 · Cited by 39
Liu, S., Shu, H., Crawford, J. A., Ma, Y., Li, C., & Tao, F. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02020-2 · Cited by 35
Erdem, A., Yildiz, E., Senturk, H., & Maral, M. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115385 · Cited by 34
Orexin pathway in Parkinson’s disease: a review
Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Zaafar, D. K., & Batiha, G. E. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08459-5 · Cited by 36
Identifying Phasic dopamine releases using DarkNet-19 Convolutional Neural Network
Al-Haija, Q. S. A., Smadi, M. A., & Al‐Bataineh, O. M. (2021) · IEEE International IOT, Electronics and Mechatronics Conference (IEMTRONICS) · doi:10.1109/iemtronics52119.2021.9422617 · Cited by 34
Zhang, C., You, X., Li, Y., Zuo, Y., Wang, W., Li, D., Huang, S., Hu, H., Yuan, F., Shao, F., et al. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.131233 · Cited by 34
López-Torres, B., Arés, I., Martínez, M., Maximiliano, J.-E., Martínez‐Larrañaga, M., Anadón, A., & Martínez, M. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113434 · Cited by 34
Mysliveček, J. (2021) · Biomedicines · doi:10.3390/biomedicines9010025 · Cited by 32
Copper selenide as multifunctional non-enzymatic glucose and dopamine sensor
Singh, H., Bernabe, J., Chern, J., & Nath, M. (2021) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-021-00227-0 · Cited by 34
Lu, K., Liu, J., Dai, X., Zhao, L. X., Yang, Y., Li, H., & Jiang, Y. (2022) · RSC Advances · doi:10.1039/d1ra07962j · Cited by 33
Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders
Jůza, R., Musílek, K., Mezeiová, E., Soukup, O., & Korábečný, J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21923 · Cited by 34
Zhu, J., Wang, W., Wang, L., Cui, S., Han, D., Liu, S., Xi, S., Xi, S., Cai, W., & Liang, P. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163869 · Cited by 32
SERS characterization of dopamine and in situ dopamine polymerization on silver nanoparticles
Badillo‐Ramírez, I., Saniger, J. M., Popp, J., & Cialla‐May, D. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp00966d · Cited by 32
Mood and behavior regulation: interaction of lithium and dopaminergic system
Mohamadian, M., Fallah, H., Ghofrani-Jahromi, Z., Rahimi-Danesh, M., Saadlou, M.-S. S. Q., & Vaseghi, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02437-1 · Cited by 33
Fang, X. J., Yuan, M., Zhao, F., Yu, A., Lin, Q., Li, S., Li, H., Wang, X., Yu, Y., Wang, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38323-w · Cited by 31
Dopamine Pharmacodynamics: New Insights
Lauretani, F., Giallauria, F., Testa, C., Zinni, C., Lorenzi, B., Zucchini, I., Salvi, M., Napoli, R., & Maggio, M. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105293 · Cited by 36
Functionalized Graphene Oxide with Chitosan for Dopamine Biosensing
Omar, A., Bayoumy, A. M., & Aly, A. A. A. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13020048 · Cited by 31
The Dopamine System: Insights between Kidney and Brain
Donato, A. D., Buonincontri, V., Borriello, G., Martinelli, G., & Mone, P. (2022) · Kidney & Blood Pressure Research · doi:10.1159/000522132 · Cited by 33
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac105.64606473 · Cited by 31
Flexible electrode based on nitrogen carbon quantum dots for dopamine detection
Paulo‐Mirasol, S., Izquierdo, C., Alemán, C., Armelin, E. A., & Torras, J. (2023) · Applied Surface Science · doi:10.1016/j.apsusc.2023.157241 · Cited by 32
Gut‐Brain Axis Impact on Canine Anxiety Disorders: New Challenges for Behavioral Veterinary Medicine
Sacoor, C., Marugg, J. D., Lima, N. R., Empadinhas, N., & Montezinho, L. (2024) · Veterinary Medicine International · doi:10.1155/2024/2856759 · Cited by 33
Govindaraju, R., Sangubotla, R., & Kim, J. (2024) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-024-00144-y · Cited by 30
High-sensitivity flexible electrochemical sensor for real-time multi-analyte sweat analysis
Zhang, Y., Sun, Y., Han, J., Zhang, M., Li, F., & Yang, D. (2025) · Talanta · doi:10.1016/j.talanta.2025.127644 · Cited by 30
Gigli, V., Tortolini, C., Capecchi, E., Angeloni, A., Lenzi, A., & Antiochia, R. (2022) · Biosensors · doi:10.3390/bios12070519 · Cited by 30
Park, J., Choi, Y., Ahn, H. M., Lee, C., Chun, H., Park, Y. M., & Kim, K. B. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.342036 · Cited by 29
Costas‐Ferreira, C., Durán, R., & Faro, L. R. F. (2023) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2023.105433 · Cited by 29
Wu, L.-Y., Zeeshan, M., Dang, Y., Zhang, Y., Liang, L.-X., Huang, J.-W., Zhou, J.-X., Guo, L.-H., Fan, Y.-Y., Sun, M.-K., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.164838 · Cited by 27
Musculoskeletal Pain in Parkinson's Disease
Li, J., Zhu, B., Gu, Z., Zhang, H., Mei, S., Ji, S., Liu, S., Han, C., Chen, H., & Chan, P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.756538 · Cited by 28
Research Progress in Pharmacological Activities and Applications of Cardiotonic Steroids
Ren, J., Gao, X., Guo, X., Wang, N., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902459 · Cited by 29
Prajapati, A., Mehan, S., Khan, Z., Chhabra, S., & Gupta, G. D. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04082-9 · Cited by 27
Singh, H., Wu, J., Lagemann, K. A. L., & Nath, M. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c05422 · Cited by 27
Rajarathinam, T., Jayaraman, S., Seol, J., Lee, J., & Chang, S. (2024) · Biosensors · doi:10.3390/bios14060262 · Cited by 27
Yue, S., Wang, T., Yang, Y., Fan, Y., Zhou, L., Li, M., & Fu, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107798 · Cited by 28
Xia, Y., Zhou, J., Liu, Y., Liu, Y., Huang, K., Yu, H., Jiang, X., & Xiong, X. (2022) · The Analyst · doi:10.1039/d2an01420c · Cited by 27
Wang, Q., Dong, X., Lu, J. N., Hu, T., & Pei, G. (2020) · Stem Cells · doi:10.1002/stem.3156 · Cited by 28
Gut-brain axis: altered microbiome and depression – review
Mohan, A., Godugu, S., Joshi, S., Shah, K. B., Vanka, S. C., Shakil, H., Dhanush, P., Veliginti, S., Sure, P. S., & Goranti, J. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000573 · Cited by 28
Dimitrov, L. V., Kaminski, J. W., Holbrook, J. R., Bitsko, R. H., Yeh, M., Courtney, J. G., O’Masta, B., Maher, B. S., Cerles, A. A., McGowan, K., et al. (2023) · Prevention Science · doi:10.1007/s11121-023-01601-6 · Cited by 27
Mata-Bermúdez, A., Trejo-Chávez, R., Martínez-Vargas, M., Pérez-Arredondo, A., Martínez-Cárdenas, M. D. L. Á., Dı́az-Ruiz, A., Rı́os, C., & Navarro, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1447688 · Cited by 27
Moritz, A. E., Free, R. B., Weiner, W. S., Akano, E. O., Gandhi, D. M., Abramyan, A. M., Keck, T. M., Ferrer, M., Hu, X., Southall, N. T., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00424 · Cited by 26
Fasciani, I., Petragnano, F., Aloisi, G., Marampon, F., Carli, M., Scarselli, M., Maggio, R., & Rossi, M. (2020) · Pharmaceuticals · doi:10.3390/ph13110388 · Cited by 26
Therapeutic potential of lipid nanosystems for the treatment of Parkinson’s disease
Preetam, S., Jonnalagadda, S., Kumar, L., Rath, R., Chattopadhyay, S., Alghamdi, B. S. A., Abuzenadah, A. M., Jha, N. K., Gautam, A., Malik, S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101965 · Cited by 28
Silver@copper-polyaniline nanotubes: Synthesis, characterization and biosensor analytical study
Saadh, M. J., AL-Salman, H. N. K., Hussein, H. H., Mahmoud, Z. H., Jasim, H. H., Ward, Z. H., Alubiady, M. H. S., Al‐Ani, A. M., Jumaa, S. S., Sayadi, H., et al. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101614 · Cited by 26
Changing the Cortical Conductor’s Tempo: Neuromodulation of the Claustrum
Wong, K. L. L., Nair, A., & Augustine, G. J. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.658228 · Cited by 31
Biomolecular Effects of Dance and Dance/Movement Therapy: A Review
Lopez-Nieves, I., & Jakobsche, C. E. (2022) · American Journal of Dance Therapy · doi:10.1007/s10465-022-09368-z · Cited by 30
Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
Savchenko, A. A., Targa, G., Fesenko, Z. S., Leo, D., Gainetdinov, R. R., & Sukhanov, I. (2023) · Biomolecules · doi:10.3390/biom13050806 · Cited by 31
Ephedrine and cocaine cause developmental neurotoxicity and abnormal behavior in zebrafish
Ma, D.-D., Shi, W., Li, S., Zhang, J., Lu, Z., Long, X.-B., Liu, X., Huang, C.-S., & Ying, G. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106765 · Cited by 25
Mejías, R., Gotor, J. J. R., Niwa, M., Krasnova, I. N., Adamczyk, A. L., Han, M., Thomas, G. M., Xi, Z., Huganir, R. L., Pletnikov, M. V., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01194-6 · Cited by 26
Electrochemical nanobiosensors equipped with peptides: a review
Negahdary, M., & Angnes, L. (2022) · Microchimica Acta · doi:10.1007/s00604-022-05184-x · Cited by 26
Gong, T., Jiang, J., Yang, S., Liu, J., Chen, L., & Zhao, J. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c02810 · Cited by 25
Applications of Polydopamine in Implant Surface Modification
Ma, T., Wang, C., Ge, X., & Zhang, Y. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300067 · Cited by 26
Li, W., Xi, Y., Wang, J., Zhang, Y., Li, H., & Liu, X. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250097 · Cited by 25
Zhang, Y., Li, N., Liu, B., & Zhang, H. (2024) · Sensors · doi:10.3390/s24020355 · Cited by 25
Identification of functional divergence sites in dopamine receptors of vertebrates
Xin, J., Fan, T., Guo, P., & Wang, J. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107140 · Cited by 25
Unveiling the PEDOT-polypyrrole hybrid electrode for the electrochemical sensing of dopamine
Sanmugam, A., Vanitha, C., Almansour, A. I., Karuppasamy, K., Maiyalagan, T., Kim, H.-S., Vikraman, D., & Alfantazi, A. M. (2025) · Scientific Reports · doi:10.1038/s41598-024-82355-1 · Cited by 25
pH‐Switchable Multi‐Enzyme‐Mimicking via Liquid Metal Nanozyme
Shen, Y., Xiaojian, X., Xing, R., Wang, Y., Su, R., Kong, J., Huang, R., Dickey, M. D., & Qi, W. (2025) · Small · doi:10.1002/smll.202502752 · Cited by 25
Souza, M. F., Medeiros, K. A. A. L., Lins, L. C. R. F., Bispo, J. M. M., de Gois, A. M., Freire, M. A. M., Marchioro, M., & dos Santos, J. R. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.10.002 · Cited by 24
Silva, B., Hidalgo, S., & Campusano, J. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229671 · Cited by 24
Liu, M., Ren, L., Zhong, X., Ding, Y., Liu, T., Liu, Z., Yang, X., Cui, L., Yang, L., Fan, Y., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00152 · Cited by 24
Nabinger, D. D., Altenhofen, S., Peixoto, J. V., da Silva, J. M. K., Gerlai, R. T., & Bonan, C. D. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110179 · Cited by 25
Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
Arioka, Y., Shishido, E., Kushima, I., Suzuki, T., Saito, R., Aiba, A., Mori, D., & Ozaki, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103138 · Cited by 25
Liu, X., Zeng, J., Yang, Y., Qi, C., Xiong, T., Wu, G., Zeng, C., & Wang, D.-X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619426 · Cited by 24
Gallo, A., Pillet, L., & Verpillot, R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111452 · Cited by 25
Knapik, J. J., Trone, D. W., Steelman, R. A., Farina, E. K., & Lieberman, H. R. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112840 · Cited by 25
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management
Wolfschlag, M., & Håkansson, A. (2023) · Pharmaceutical Medicine · doi:10.1007/s40290-022-00453-9 · Cited by 25
Nguyen, H. T. N., Kato, H., Sato, H., Yamaza, H., Sakai, Y., Ohga, S., Nonaka, K., & Masuda, K. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.084 · Cited by 23
Paudel, P., Park, S. E., Seong, S. H., Jung, H. A., & Choi, J. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246232 · Cited by 24
Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets
Lee, H., Elkamhawy, A., Rakhalskaya, P., Lu, Q., Nada, H., Quan, G., & Lee, K. (2024) · Pharmaceuticals · doi:10.3390/ph17121688 · Cited by 23
Gut Microbiota: A New Challenge in Mood Disorder Research
Marano, G., Rossi, S., Sfratta, G., Traversi, G., Lisci, F. M., Anesini, M. B., Pola, R., Gasbarrini, A., Gaetani, E., & Mazza, M. (2025) · Life · doi:10.3390/life15040593 · Cited by 29
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus
Kabir, M. T., Mitu, J. F., Akter, R., Akhtar, M. F., Saleem, A., Al‐Harrasi, A., Bhatia, S., Rahman, M. S., Damiri, F., Berrada, M., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20445-1 · Cited by 23
Hellrung, L., Kirschner, M., Sulzer, J. S., Sladky, R., Scharnowski, F., Herdener, M., & Tobler, P. N. (2022) · Communications Biology · doi:10.1038/s42003-022-03756-4 · Cited by 23
3D printed neural tissues with in situ optical dopamine sensors
Li, J., Reimers, A., Dang, K. M., Brunk, M. G. K., Drewes, J., Hirsch, P., Willems, C., Schmelzer, C. E. H., Groth, T., Nia, A. S., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114942 · Cited by 21
Past, Present, and Future of Tools for Dopamine Detection
Zheng, Y., & Li, Y. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.06.025 · Cited by 27
Ahmad, K., Nde, D. T., Khan, R. A., & Raza, W. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.134606 · Cited by 23
The development of monoaminergic neurotransmitter systems in childhood and adolescence
Pitzer, M. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.02.002 · Cited by 25
Wilbraham, D., Biglan, K., Svensson, K. A., Tsai, M. C., & Kielbasa, W. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.874 · Cited by 25
A new perspective on hippocampal synaptic plasticity and post‐stroke depression
Sun, N., Cui, W., Min, X., Zhang, G., Liu, J., & Wu, H. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16093 · Cited by 24
Peng, Z., Jia, Q., Mao, J., Luo, X., Huang, A., Zheng, H., Jiang, S., Ma, Q., Ma, C., & Yi, Q. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1439727 · Cited by 29
Dopaminergic Modulation of Glomerular Circuits in the Mouse Olfactory Bulb
Liu, S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00172 · Cited by 23
The neurochemistry of hypnotic suggestion
Acunzo, D. J., Oakley, D. A., & Terhune, D. B. (2021) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2020.1865869 · Cited by 25
Tyrosine-Decorated Gold Nanoclusters Chelated Cerium(III) for Fluorescence Detection of Dopamine
Wu, F., Zhu, J., Weng, G., Li, J.-J., & Zhao, J. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c02982 · Cited by 23
The dopaminergic control of Cushing’s syndrome
Pivonello, R., Pivonello, C., Simeoli, C., Martino, M. C. D., & Colao, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01661-x · Cited by 22
Wei, Z., Wei, M., Yang, X., Xu, Y., Gao, S., & Ren, K. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9176923 · Cited by 25
Mendivil‐Perez, M., Felizardo-Otalvaro, A. A., Jiménez-Del-Río, M., & Velez‐Pardo, C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00176 · Cited by 22
The Role of Dopamine in Repurposing Drugs for Oncology
Moura, C. V., & Vale, N. (2023) · Biomedicines · doi:10.3390/biomedicines11071917 · Cited by 22
Does gut brain axis has an impact on Parkinson’s disease (PD)?
Elangovan, A., Dahiya, B., Kirola, L., Iyer, M., Jeeth, P., Maharaj, S., Kumari, N., Lakhanpal, V., Michel, T. M., Rao, K. R. S. S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102171 · Cited by 22
Pérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21
Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms
Tai, M. D. S., Gamiz-Arco, G., & Martı́nez, A. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231061 · Cited by 21
Marchetti, B., Giachino, C., Tirolo, C., & Serapide, M. F. (2022) · Aging Cell · doi:10.1111/acel.13575 · Cited by 22
Ortega, Á., Salazar, J. J., Galbán, N., Rojas, M., Ariza, D. V., Chávez-Castillo, M., Nava, M., Riaño-Garzón, M., Díaz-Camargo, E. A., Medina, Ó., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084196 · Cited by 22
Hattori, T., Reynolds, R. C., Wiggs, E. A., Horovitz, S. G., Lungu, C., Chen, G., Yasuda, E., & Hallett, M. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103100 · Cited by 22
Mallien, A. S., Becker, L. K., Pfeiffer, N., Terraneo, F., Hahn, M., Middelman, A., Palme, R., Creutzberg, K. C., Begni, V., Riva, M. A., et al. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.924603 · Cited by 20
Metadata
- Authors
- Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G.
- Affiliations
- Universidade de São Paulo (BR)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Bittencourt, Jackson C.
- Correa, Ricardo G.
- ORCID
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2018-11-16
- Volume
- 39
- Issue
- 1
- Pages
- 31-59
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11469830
- OpenAlex
- W2901208536
- Cited by
- 1,073
- References
- 472
- Citations by year
- 2026: 141 · 2025: 174 · 2024: 214 · 2023: 199 · 2022: 148 · 2021: 105 · 2020: 64 · 2019: 27
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine, dopaminergic signaling, dopamine receptors, G protein-coupled receptors, catecholamine neurotransmitters, neuromodulation, neurodegenerative diseases, Parkinson's disease, schizophrenia, Huntington's disease, attention deficit hyperactivity disorder, addiction, dopaminergic therapy, reward and motivation
- MeSH terms
- Animals, Brain, Dopamine, Humans, Models, Biological, Nervous System Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review